Compare Quest Diagnostics Inc (DGX) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Lam Research Corporation — how do they compare? Quest Diagnostics Inc trades at $205.48 (market cap $22.80B), while Lam Research Corporation trades at $341.16 (market cap $432.82B). The key difference: Lam Research Corporation is far larger — about 19× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.67%). Which is the better fit depends on your goals.
| DGX | LRCX | |
|---|---|---|
Market Cap | $22.80B | $432.82B |
Sector | Health | Technology |
52-Week High | $216.02 | $433.33 |
52-Week Low | $166.42 | $94.84 |
Enterprise Value | $28.82B | $431.81B |
Dividend Yield | 1.67% | 0.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
Lam Research (LRCX) trades at $329.92, down 5.83% amid broader semiconductor sector volatility. The stock shows strong fundamentals with Q1 2026 EPS of $1.47 beating estimates by 8%, marking the third consecutive quarterly beat. Revenue grew 23.8% year-over-year to $18.44B in 2025, while net income margin expanded to 30.94%. Technical indicators show bearish momentum with the stock trading below key resistance at $332, though RSI at 22.63 suggests potential oversold conditions. Recent news highlights AI-driven demand for semiconductor equipment as a key growth catalyst.
LRCX presents a compelling long-term opportunity with 78% analyst buy ratings and $393 consensus price target (19% upside), though elevated P/E of 62.37 warrants caution. Strong cash flow generation ($6.17B operating cash flow) supports dividend payments and strategic investments. Risks include semiconductor cycle volatility and competitive pressures, but AI infrastructure spending provides durable tailwinds for the wafer fabrication equipment leader.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
